Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Factor XIII in patients with alcohol abuse disorder undergoing elective surgery
ISRCTN41162940Phase 4Terminated
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Aug 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in alcohol use disorder (AUD) comparing Fibrogammin with Placebo (2 arms). Primary endpoint: Modified Factor XIII levels and immune suppression. Started Aug 2007; status: terminated.
02
Drugs
Factor XIII (human)
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on ISRCTN41162940.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN41162940.